InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Detke Michael J., Directeur Médical. Insider active across 1 companies, notably Cortexyme, Inc.. Cumulatively, 5 disclosures have been published. The latest transaction was disclosed on 3 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
0140,000 shares0
Common Stock
SEC:0001209191-22-016428:0·
€19,02210,000 shares@ €1.902244.5% of flow
Common Stock
SEC:0001209191-21-051214·
€19,02210,000 shares@ €1.902222.2% of flow
Common Stock
SEC:0001209191-21-051214:0·
€23,76212,600 shares@ €1.885955.5% of flow
Common Stock
SEC:0001209191-21-045948·
€23,76212,600 shares@ €1.885927.8% of flow
Common Stock
SEC:0001209191-21-045948:0·
5 of 5 declarations
About Detke Michael J.
Michael J. Detke is the Chief Medical Officer at Cortexyme, Inc. In this role, he is responsible for leading the company's medical and clinical initiatives. Detke brings valuable expertise in drug research and development, contributing to innovation in healthcare. His commitment to improving patient care is essential in guiding Cortexyme's projects. He collaborates with research teams to ensure the success of clinical trials and the development of new treatments.
